期刊文献+

脂联素对人脐静脉内皮细胞保护作用的实验研究

Protective effect of adiponectin on the human umbilical vein endothelial cells in vitro
在线阅读 下载PDF
导出
摘要 目的体外培养人脐静脉血管内皮细胞(HUVEC),加入低密度脂蛋白(LDL)建立细胞损伤模型,观察脂联素(APN)对模型细胞结构和功能的影响。方法观察对照组、LDL损伤组、APN预处理组和APN干预组内皮细胞(EC)的形态改变,测定细胞活性,测定细胞培养上清中一氧化氮(NO)、乳酸脱氢酶(LDH)和6-酮前列腺(6-keto-PGF1)的含量变化,测定细胞中一氧化氮合酶(NOS)的含量。结果与正常细胞对照组比较,LDL损伤组的细胞形态明显改变,细胞存活率明显降低,LDH释放明显增高,NO、NOS和6-keto-PGF1合成明显降低(P<0.01);而APN预处理组和干预组能明显降低LDH释放,促进NO、NOS和6-keto-PGF1合成(P<0.01)。结论 APN对EC有一定的保护作用,能拮抗LDL对EC的损伤。 Objective To observe the effect of lipoprotein (LDL) on the cultured human umbilical vein endothelial cells (ECs) damage models established by adding low-density lipoprotein (LDL) in vitro and to observe the effect of adiponectin (APN) on the Ecs.Methods The cultured ECs were divided into five groups. GroupⅠ:normal Ecs; groupⅡ:ECs damaged by LDL;group Ⅲ:ECs cocultured with APN;group Ⅳ:LDL injuried model pre-treated with APN;group Ⅴ:LDL injuried model treated with APN. The morphological changes and survival rate of the ECs were observed,and the levels of nitric oxide (NO),nitric oxide synthase (NOS),lactate dehydrogenase (LDH) and 6-keto prostaglandin (6-keto-PGF1 ) were detected.Results As compared with the normal ECs,the cell morphous in LDL injury group were significantly changed,and the survival rate was significantly lower,and the levels of LDH were significantly increased,however,the levels of 6-keto-PGF1,NO and NOS were significantly decreased(P〈0.01).When the ECs pre-treated or treated with APN,the release of LDH was inhibited,and the synthesis of 6-keto-PGF1,NO and NOS was obviously enhanced(P〈0.01).Conclusion The APN has certain protective effect,which can relieve the damage of LDL on EC.
出处 《河北医药》 CAS 2010年第21期2969-2971,共3页 Hebei Medical Journal
关键词 脂联素 脐静脉血管内皮细胞 一氧化氮 一氧化氮合酶 乳酸脱氢酶 6-酮前列腺素 adiponectin human umbilical vein endothelial cells nitric oxide nitric oxide synthase lactate dehydrogenase 6-keto prostaglandin
  • 相关文献

参考文献11

  • 1Wiecek A,Adamczak M,Chudek J.Adiponectin-an adipokine with unique metabolic properties.Nephrol Dial Transplant,2007,22:981-988.
  • 2Kadowaki T,Yamauchi T.Adiponectin and Adiponectin Receptors.Endocr Rev,2005,26:439-451.
  • 3Wang ZV,Scherer PE.Adiponectin,Cardiovascular Function and Hypertension.Hypertension,2008,51:8-14.
  • 4Maiolino G,Cesari M,Sticchi D,et al.Plasma Adiponectin for Prediction of Cardiovascular Events and Mortality in High-Risk Patients.J Clin Endocrinol Metab,2008,93:3333-3340.
  • 5Wolk R,Berger P,Lennon RJ,et al.Association between plasma adiponectin levels and unstable coronary syndromes.Eur Heart J,2007,28:292-298.
  • 6Ekmekci H,Ekmekci OB.The Role of Adiponectin in Atherosclerosis and Thrombosis.Clinical and Applied Thrombosis,2006,12:163-168.
  • 7Szmitko PE,Teoh H,Stewart DJ,et al.Adiponectin and cardiovascular disease:state of the art.Am J Physiol Heart Circ Physiol,2007,292:1655-1663.
  • 8杨靖,杨慧君,李朝晖.脂联素与动脉粥样硬化[J].河北医药,2008,30(3):366-367. 被引量:5
  • 9Chen H,Montagnani M,Funahashi T,et al.Adiponectin stimulates production of nitric oxide in vascular endothelial cells.J Biol Chem,2003,278:45021-45026.
  • 10Tamada T,Nara M,Kanatsuka H,et al.A Potentiating Effect of Endogenous NO in the Physiologic Secretion from Airway Submucosal Glands.Am J Respir Cell Mol Biol,2007,37:357-365.

二级参考文献27

  • 1裴强,秦永文,吴弘,郑兴,丁继军.血清脂联素水平与冠状动脉病变程度的关系[J].临床心血管病杂志,2004,20(10):619-621. 被引量:33
  • 2黄芳,李向平.代谢综合征与血管内皮功能紊乱[J].疑难病杂志,2006,5(3):235-237. 被引量:14
  • 3Stefan E,Mareike F,Kerstin G,et al.Association between adiponectin and mediators of inflammation in obese women[J].Diabetes,2003,52(4):942-946.
  • 4Wannamethee SG,Tchernova J,Whincup P,et al.Associations of adiponectin with metabolic and vascular risk parameters in the British Regional Heart Study reveal stronger links to insulin resistance-related than to coronary heart disease risk-related parameters[J].Int J Obes(Lond),2007,Jan 30:[Epub ahead of print]
  • 5Celermajer DS,Sorensen KE,Gooch NM,et al.Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis[J].Lancet,1992,340(8 828):1 111-1 115.
  • 6Ouchi N,Kihara S,Arita Y,et al.Novel modulator for endothelial adhesion molecules:adipocyte-derived plasma protein adiponectin[J].Circulation,1999,100(25):2 473-2 476.
  • 7Kozlowake J,Kowalska I.The adiponectin role in patheogenesis of metabolic syndrome and cardiovascular disease[J].Endokrynol Pol,2006,57(6):626-632.
  • 8Ouchi N, Ohishi M, Kihara S, et al. Association of hypo- adiponectinemia with impaired vasoreactivity. Hypertension,2003,42:231-234.
  • 9Okamoto Y, Kihara S, Ouchi N, et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation, 2002,106: 2767-2770.
  • 10Haluzik M, Parizkova J, Haluzik MM. Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol Res, 2004, 53:123-129.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部